


To maximise long-term capital growth by investing primarily in continental European equities.
| Name | % Net Assets |
|---|---|
| Total | 3.7% |
| Banco Santander | 3.6% |
| BNP Paribas | 3.0% |
| Credit Suisse | 2.7% |
| Novartis | 2.5% |
| Nestle | 2.5% |
| Telefonica | 2.2% |
| ENI | 2.1% |
| Deutsche Bank | 2.0% |
| Cermaq | 1.8% |
| Key | % Net Assets |
|---|---|
| 3.7% | |
| 3.6% | |
| 3.0% | |
| 2.7% | |
| 87% |
| Date | 09-Sep-2022 |
|---|---|
| NAV | 270.30p |
| Currency | GBP |
| Change | 4.70p |
| % | 1.77% |
| YTD change | 270.30p |
| YTD % | n/a |
| Fund Inception | 30/09/2004 |
|---|---|
| Fund Manager | Jon Ingram / John Baker |
| TER | 1.68 (31-Jan-2013) |
| Minimum Investment | |
|---|---|
| Initial | £1000 |
| Additional | £100 |
| Savings | £100 |
| Charges | |
|---|---|
| Initial | 4.25% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.15 |
You are here: research